TRUFF OTC
Rhelion Life Sciences Corp.
1W: -17.3%
1M: -10.9%
3M: -9.4%
YTD: +18.4%
1Y: -18.0%
3Y: -62.7%
5Y: -89.1%
$0.02
-0.00 (-7.83%)
Weekly Expected Move ±19.7%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$15M
-31.3% ▼
5Y CAGR: +29.7%
Total Liabilities
$3M
-13.5% ▼
5Y CAGR: -8.1%
Shareholders Equity
$12M
-31.0% ▼
Cash & Investments
$9M
-26.2% ▼
5Y CAGR: +35.8%
Total Debt
$1M
-35.0% ▼
5Y CAGR: +74.9%
Net Debt
-$7M
+30.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $31M | $18M | $14M | $12M | $8M |
| Short-Term Investments | $2M | $45K | $0 | $0 | $582K |
| Cash & ST Investments | $33M | $19M | $14M | $12M | $9M |
| Net Receivables | $381K | $883K | $1M | $404K | $479K |
| Inventory | $438K | $741K | $874K | $1M | $846K |
| Other Current Assets | $143K | $0 | $200K | $565K | $2M |
| Total Current Assets | $34M | $22M | $17M | $15M | $12M |
| Property, Plant & Equip. | $272K | $5M | $6M | $6M | $2M |
| Goodwill & Intangibles | $2M | $2M | $334K | $22K | $0 |
| Long-Term Investments | $682K | $865K | $1M | $779K | $599K |
| Other Non-Current Assets | -$682K | $28K | $0 | $0 | $0 |
| Total Non-Current Assets | $2M | $8M | $7M | $6M | $2M |
| Total Assets | $36M | $30M | $24M | $21M | $15M |
| — Liabilities — | |||||
| Accounts Payable | $459K | $624K | $921K | $626K | $632K |
| Short-Term Debt | $52K | $1M | $1M | $2M | $1M |
| Deferred Revenue | -$459K | $669K | $0 | $0 | $0 |
| Other Current Liabilities | $1M | $48K | $10K | $0 | $0 |
| Total Current Liabilities | $1M | $3M | $3M | $3M | $3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $965K | $695K | $411K | $0 | $0 |
| Total Non-Current Liabilities | $1M | $1M | $702K | $617K | $223K |
| Total Liabilities | $2M | $4M | $4M | $4M | $3M |
| — Equity — | |||||
| Common Stock | $31M | $42M | $42M | $43M | $44M |
| Retained Earnings | -$11M | -$31M | -$38M | -$42M | -$48M |
| Accumulated OCI | -$16K | $45K | $11M | $51K | $102K |
| Total Stockholders Equity | $34M | $26M | $20M | $17M | $12M |
| Total Liabilities & Equity | $36M | $30M | $24M | $21M | $15M |
| — Key Metrics — | |||||
| Total Debt | $866K | $2M | $2M | $2M | $1M |
| Net Debt | -$30M | -$17M | -$12M | -$10M | -$7M |
| Total Investments | $2M | $911K | $1M | $779K | $1M |